Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of $16.22, $1.00 better than the analyst estimate of $15.22. Revenue for the quarter came in at $9 million versus the consensus estimate of $9.47 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.